Epkinly (Epcoritamab)
Epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial · INJECTION · PBS code 14803D
AUTHORITY_REQUIREDWhat it costs
AU$769.23 PBS-determined price per 1 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2025-05-01.
- • Repeats: 1.
- • PBS program: CT.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Induction treatment
The condition must have relapsed, or be refractory to, at least two prior systemic therapies; AND
Patient must have a WHO performance status of no higher than 2; AND
Patient must have previously received treatment with chimeric antigen receptor-T (CAR-T) cell therapy for this condition; or
Patient must be currently unable to receive treatment with CAR-T cell therapy for this condition; AND
Patient must not be eligible for stem cell transplantation; AND
Patient must not have received prior treatment with a PBS-subsidised CD20xCD3 bispecific monoclonal antibody; AND
The treatment must be discontinued in patients who experience disease progression whilst on treatment.
Prior systemic therapy may include autologous stem cell transplant.
Definition of patients unable to receive treatment with CAR-T cell therapy for this condition include geographical, psychosocial, clinical ineligibility or urgency.
Sponsor: AbbVie Pty Ltd ABN 48 156 384 262
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.